Pharmacologic Treatment of Attention Deficit-Hyperactivity Disorder

N Engl J Med. 2020 Sep 10;383(11):1050-1056. doi: 10.1056/NEJMra1917069.
No abstract available

Publication types

  • Review

MeSH terms

  • Adolescent
  • Adult
  • Amphetamines / adverse effects
  • Amphetamines / therapeutic use
  • Atomoxetine Hydrochloride / therapeutic use
  • Attention Deficit Disorder with Hyperactivity / drug therapy*
  • Child
  • Child, Preschool
  • Growth / drug effects
  • Guanfacine / adverse effects
  • Guanfacine / therapeutic use
  • Heart Rate / drug effects
  • Humans
  • Hypertension / chemically induced
  • Methylphenidate / therapeutic use
  • Patient Dropouts
  • Polymers / adverse effects
  • Polymers / therapeutic use
  • Practice Guidelines as Topic
  • Treatment Outcome

Substances

  • Amphetamines
  • Polymers
  • Methylphenidate
  • Guanfacine
  • Atomoxetine Hydrochloride
  • conidine